Overview

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of age and BMI on the pharmacokinetics and safety of Sancuso®.
Phase:
Phase 1
Details
Lead Sponsor:
Prostrakan Pharmaceuticals
Treatments:
Granisetron